Globeflex Capital L P Charles River Laboratories International, Inc. Transaction History

Globeflex Capital L P

$1.03 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$255.51 - $362.11 $320,409 - $454,085	-1,254 Reduced 21.64%	4,541 $1.29 Million
Q3 2021 Nov 12, 2021	SELL	$372.64 - $458.3 $293,640 - $361,140	-788 Reduced 11.97%	5,795 $2.39 Million
Q2 2021 Aug 12, 2021	SELL	$294.17 - $371.65 $58,245 - $73,586	-198 Reduced 2.92%	6,583 $2.44 Million
Q1 2021 May 14, 2021	BUY	$249.67 - $299.48 $24,967 - $29,948	100 Added 1.5%	6,781 $1.97 Million
Q4 2020 Feb 11, 2021	SELL	$222.0 - $252.62 $98,346 - $111,910	-443 Reduced 6.22%	6,681 $1.67 Million
Q3 2020 Nov 13, 2020	SELL	$175.56 - $226.45 $490,514 - $632,701	-2,794 Reduced 28.17%	7,124 $1.61 Million
Q2 2020 Aug 12, 2020	SELL	$118.84 - $189.72 $600,023 - $957,896	-5,049 Reduced 33.73%	9,918 $1.73 Million
Q1 2020 May 13, 2020	SELL	$98.9 - $178.34 $109,383 - $197,244	-1,106 Reduced 6.88%	14,967 $1.89 Million
Q4 2019 Feb 07, 2020	SELL	$126.05 - $152.76 $446,847 - $541,534	-3,545 Reduced 18.07%	16,073 $2.46 Million
Q3 2019 Nov 13, 2019	BUY	$125.07 - $143.67 $276,029 - $317,079	2,207 Added 12.68%	19,618 $2.6 Million
Q2 2019 Aug 12, 2019	BUY	$123.4 - $148.55 $116,613 - $140,379	945 Added 5.74%	17,411 $2.47 Million
Q1 2019 May 10, 2019	SELL	$104.82 - $146.73 $206,390 - $288,911	-1,969 Reduced 10.68%	16,466 $2.39 Million
Q4 2018 Feb 14, 2019	SELL	$105.09 - $137.23 $45,609 - $59,557	-434 Reduced 2.3%	18,435 $2.09 Million
Q3 2018 Nov 09, 2018	SELL	$112.11 - $134.54 $16,031 - $19,239	-143 Reduced 0.75%	18,869 $2.54 Million
Q2 2018 Aug 10, 2018	SELL	$102.37 - $117.25 $145,672 - $166,846	-1,423 Reduced 6.96%	19,012 $2.13 Million
Q1 2018 May 14, 2018	SELL	$98.19 - $115.2 $604,850 - $709,632	-6,160 Reduced 23.16%	20,435 $2.18 Million
Q4 2017 Feb 13, 2018	SELL	$100.43 - $118.09 $121,018 - $142,298	-1,205 Reduced 4.33%	26,595 $2.91 Million
Q3 2017 Nov 13, 2017	BUY	$96.72 - $109.26 $2.69 Million - $3.04 Million	27,800	27,800 $3 Million

Others Institutions Holding CRL

# of Institutions

698

Shares Held

52.3M

Call Options Held

259K

Put Options Held

463K

Vanguard Group Inc Valley Forge, PA

6.1M
Shares

$1.21 Billion
0.02% of portfolio
Black Rock Inc. New York, NY

5.09M
Shares

$1.01 Billion
0.02% of portfolio
Wellington Management Group LLP Boston, MA

3.74M
Shares

$745 Million
0.13% of portfolio
State Street Corp Boston, MA

2.13M
Shares

$424 Million
0.02% of portfolio
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA

1.94M
Shares

$386 Million
0.87% of portfolio

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Globeflex Capital L P, based on Form 13F filings with the SEC.

News

Stay updated on Globeflex Capital L P with notifications on news.

Account